Learn more

NASCACELL GMBH

Overview
  • Total Patents
    14
About

NASCACELL GMBH has a total of 14 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Germany, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and pharmaceuticals are KAWAOKA YOSHIHIRO, VITRISA THERAPEUTICS INC and CHINA AGRICULTURAL VET BIO SCIENCE AND TECH CO LTD.

Patent filings per year

Chart showing NASCACELL GMBHs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Famulok Michael 13
#2 Blind Michael 10
#3 Najafi-Shoushtari Seyed Hani 5
#4 Jenne Andreas 4
#5 Hartig Joerg 3
#6 Kolanus Waldemar 3
#7 Mayer Guenter 2
#8 Hartig Jorg 2
#9 Proske Daniela 2

Latest patents

Publication Filing date Title
US2007287153A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
AU2002342672A1 Method for screening for inhibitors of protein/protein interaction and corresponding ribozymes
EP1333090A1 Prionprotein-specific aptamers
AU3573702A Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions
DE10144647A1 New allosterically regulatable hairpin ribozyme, useful for identifying compounds that bind specific targets, has extra sequence between substrate binding and catalytic domains
DE10144355A1 Identifying agents that inhibit the function of specific RNA, useful e.g. for treating human or feline immune deficiency virus, comprises using a target-reporter construct prepared from a reporter ribozyme domain
DE10116829A1 Neuropeptide binding nucleic acids
EP1223216A1 Intracellular nucleic acid inhibitors of small guanine-nucleotide-exchange factors
DE10057853A1 Identifying agents that inhibit the function of specific RNA, useful e.g. for treating human or feline immune deficiency virus, comprises using a target-reporter construct prepared from a reporter ribozyme domain
DE10046913A1 Expression system for functional nucleic acids